Next Article in Journal
Establishing a Rapid Enrichment Medium for Bacillus cereus to Shorten Detection Time
Previous Article in Journal
A Konjac Glucomannan-Based Antibacterial Packaging Film with Humidity-Triggered Release of Cinnamaldehyde
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Systematic Review

Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis

Department of Food and Nutrition, Hanyang University, Seoul 04763, Republic of Korea
*
Author to whom correspondence should be addressed.
Foods 2026, 15(3), 465; https://doi.org/10.3390/foods15030465
Submission received: 6 January 2026 / Revised: 26 January 2026 / Accepted: 26 January 2026 / Published: 29 January 2026

Abstract

Dyslipidemia, characterized by elevated triglyceride (TG), total cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels, is a major cardiovascular risk factor. However, evidence regarding the lipid-modulating efficacy of Lactobacillus rhamnosus and Lactobacillus casei remains limited. This systematic review and meta-analysis (PROSPERO: CRD420251153531) evaluated their lipid-modulating effects in preclinical dyslipidemia models. A comprehensive search of four databases up to July 2025 identified 12 studies. Risk of bias was assessed using the SYRCLE tool. Random-effects meta-analyses were conducted to estimate standardized mean differences (SMDs) and 95% confidence intervals (CIs): probiotics significantly reduced TG (SMD: −1.38; 95% CI: from −1.92 to −0.84), TC (SMD: −0.85; 95% CI: from −1.20 to −0.42), and LDL-C levels (SMD: −1.59; 95% CI: from −2.16 to −1.02; all p < 0.001). In contrast, no significant effect was observed on high-density lipoprotein cholesterol levels (SMD: 0.18; 95% CI: from −0.35 to 0.72; p = 0.5044). Heterogeneity was moderate to substantial (I2 = 36–51%), although publication bias for TC and LDL-C suggests cautious interpretation of results. The lipid-lowering effects are likely mediated by bile salt hydrolase activity and short-chain fatty acid production along the gut–liver axis. These findings support L. rhamnosus as a potential adjunctive nutritional strategy for dyslipidemia management.
Keywords: dyslipidemia; Lactobacillus rhamnosus; Lactobacillus casei; Lacticaseibacillus; meta-analysis; systematic review dyslipidemia; Lactobacillus rhamnosus; Lactobacillus casei; Lacticaseibacillus; meta-analysis; systematic review

Share and Cite

MDPI and ACS Style

Chung, S.; Jeong, J.; Park, Y.; Lee, B.; Kang, S.; Go, G.-w. Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis. Foods 2026, 15, 465. https://doi.org/10.3390/foods15030465

AMA Style

Chung S, Jeong J, Park Y, Lee B, Kang S, Go G-w. Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis. Foods. 2026; 15(3):465. https://doi.org/10.3390/foods15030465

Chicago/Turabian Style

Chung, Sungmin, Jiill Jeong, Yeonwoo Park, Bogyeong Lee, Sumin Kang, and Gwang-woong Go. 2026. "Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis" Foods 15, no. 3: 465. https://doi.org/10.3390/foods15030465

APA Style

Chung, S., Jeong, J., Park, Y., Lee, B., Kang, S., & Go, G.-w. (2026). Improving Lipid Profiles Through Lactobacillus rhamnosus Supplementation in Dyslipidemic Animal Models: A Systematic Review and Meta-Analysis. Foods, 15(3), 465. https://doi.org/10.3390/foods15030465

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Article metric data becomes available approximately 24 hours after publication online.
Back to TopTop